The FDA is poised to rule on the therapeutic use of the drug ecstasy, a potential turning point in the emerging field of psychedelic medicines.
The FDA is poised to rule on the therapeutic use of the drug ecstasy, a potential turning point in the emerging field of psychedelic medicines.